Clinical trial
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer…
NCT00480623 · Agennix, Industry · Terminated
Key facts
| NCT number | NCT00480623 |
|---|---|
| Title | A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence |
| Official title | A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy |
| Lead sponsor | Agennix, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Satraplatin plus radiation therapy |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 31, 2007 |
| Last update posted | Mar 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: